Novartis Pharmaceuticals Corp. recalls Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New J…
- Recall date
- May 11, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1309-2019
- FDA classification
- Class I
- Brand / firm
- Novartis Pharmaceuticals Corp.
- Sold / distributed
- Nationwide with in the United States
Why it was recalled
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.
Get recall alerts
Free email alert whenever Novartis Pharmaceuticals Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Novartis Pharmaceuticals Corp.